Daito Pharmaceutical Co (TSE:4577) Buyback Yield %: 0.00 (As of Jul. 17, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4577 Daito Pharmaceutical Co Ltd TSE:4577
73 GF Score
Price 円1,300.00
GF Value 円1,277.81
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Daito Pharmaceutical Co Buyback Yield %?

Daito Pharmaceutical Co TSE:4577 -0.99% 73 Buyback Yield % is 0.00 as of Jul. 17, 2026. GuruFocus rates TSE:4577 with a GF Score™ of 73/100 and a GF Value™ of 円1,277.81 (Fairly Valued). The stock has 3 warning signs investors should review. Among 291 Drug Manufacturers companies, Daito Pharmaceutical Co ranks worse than 343642.27% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Daito Pharmaceutical Co's current buyback yield was 0.00%.

Daito Pharmaceutical Co Buyback Yield % Related Terms

Daito Pharmaceutical Co Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Daito Pharmaceutical Co's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Daito Pharmaceutical Co Buyback Yield % Chart

Daito Pharmaceutical Co Annual Data
Trend May17 May18 May19 May20 May21 May22 May23 May24 May25 May26
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.05 -0.58 3.45 2.11 4.72

Daito Pharmaceutical Co Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.11 0.00 0.00 0.00 0.00

TSE:4577 vs ZTS, UTHR: Buyback Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Daito Pharmaceutical Co's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Daito Pharmaceutical Co Buyback Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Daito Pharmaceutical Co's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Daito Pharmaceutical Co's Buyback Yield % falls into.


TSE:4577
73GF Score
Daito Pharmaceutical Co Ltd TSE:4577
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Daito Pharmaceutical Co Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Daito Pharmaceutical Co's Buyback Yield for the fiscal year that ended in May. 2026 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (-1631 + 0) / 34550.288
=4.72%

Daito Pharmaceutical Co's annualized Buyback Yield for the quarter that ended in Feb. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 0) / 42871.08
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of 0.00 mean?
Daito Pharmaceutical Co (TSE:4577) has a Buyback Yield % of 0.00 as of Jul. 17, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Daito Pharmaceutical Co and its competitors. According to the industry distribution chart, Daito Pharmaceutical Co ranks #999999 out of 291 companies in the Drug Manufacturers industry.
Is Daito Pharmaceutical Co's Buyback Yield % too high?
Daito Pharmaceutical Co's current Buyback Yield % is 0.00. Based on the distribution chart, Daito Pharmaceutical Co ranks #999999 out of 291 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Daito Pharmaceutical Co has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Daito Pharmaceutical Co's Buyback Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Daito Pharmaceutical Co ranks #999999 out of 291 companies for Buyback Yield %. This places Daito Pharmaceutical Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Drug Manufacturers company?
A good Buyback Yield % depends on the Drug Manufacturers industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Daito Pharmaceutical Co and its competitors. Daito Pharmaceutical Co's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daito Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Daito Pharmaceutical Co (TSE:4577) is currently considered Fairly Valued. The stock's GF Value™ is 円1,277.81, compared to a current price of 円1,300.00 — trading 1.7% above its estimated fair value. The current Buyback Yield % is 0.00. Daito Pharmaceutical Co's overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Daito Pharmaceutical Co (TSE:4577), the current Buyback Yield % is 0.00 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Daito Pharmaceutical Co (TSE:4577) Overvalued in 2026?

Based on GuruFocus' analysis, Daito Pharmaceutical Co stock appears to be overvalued. The current stock price of 円1,300.00 is trading 1.7% above its estimated GF Value™ of 円1,277.81. GuruFocus considers Daito Pharmaceutical Co to be Fairly Valued.

Key valuation signals for TSE:4577:

  • Buyback Yield %: 0.00
  • GF Value™: 円1,277.81 vs. price of 円1,300.00 (1.7% above fair value)
  • GF Score™: 73/100 with 3 warning signs

No single metric tells the full story. See the TSE:4577 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Daito Pharmaceutical Co Business Description

Address 326 Yokamachi, Toyama, JPN, 939-8567
Daito Pharmaceutical Co Ltd is engaged in the research and development of pharmaceutical products. The company also undertakes contract manufacturing.
73GF Score

Get the complete analysis for TSE:4577

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,300.00
Price
円1,277.81
GF Value